GSK plc
The Executive Director, Strategic Labelling at GSK leads global development and governance of product labelling for vaccines and medicines, guiding label strategy from early lifecycle through commercialization. The role ensures alignment with regulatory requirements and company standards while engaging senior stakeholders across R&D, Regulatory, Safety, and Commercial functions. The position represents GSK externally and drives labelling strategy to support the company’s portfolio and global health objectives.
Headquarters
London, England, United Kingdom
Company Size
10001+ employees
Founded
1830
At GSK, we unite science, technology and talent to get ahead of disease together
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GSK plc.
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
Dec 19, 2025
Labelling Strategy Director
American Association of Physicists in Medicine
Global Labelling Director, Content
Novartis
Labelling Strategy Director
AstraZeneca
Director, Regulatory Affairs Labelling, Europe
Revolution Medicines
Associate Director, Global Labelling Strategy
AstraZeneca
Senior Manager, Core Labelling Strategy (12 month agency contract)
Viatris